Julian Upton, journalist at Pharmaceutical Executive, interviewed the Avicenna Alliance Board Members
Emmanuelle Voisin, Policy Development Working Group leader and Thierry Marchal, Secretary General, who explained why in silico technologies are a game changer today and why major evolutions are expected in the next few years. Julian nicely synthesized the vision in an article on entitled “A coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction”.